XML 37 R31.htm IDEA: XBRL DOCUMENT v2.3.0.15
Business Segment Information (Tables)
9 Months Ended
Sep. 24, 2011
Business Segment Information 
Schedule of sales and other financial information by business segment

 
  Three Months Ended   Nine Months Ended  
 
  September 24, 2011   September 25, 2010   September 24, 2011   September 25, 2010  

Research Models and Services

                         
 

Net sales

  $ 171,471   $ 159,259   $ 523,005   $ 498,604  
 

Gross margin

    70,514     64,383     222,660     210,008  
 

Operating income

    48,534     42,817     155,967     140,059  
 

Depreciation and amortization

    9,327     9,422     27,914     27,954  
 

Capital expenditures

    5,789     4,622     14,202     15,827  

Preclinical Services

                         
 

Net sales

  $ 106,108   $ 111,626   $ 328,680   $ 353,160  
 

Gross margin

    22,202     26,117     79,014     81,447  
 

Operating income

    3,663     5,178     20,844     12,116  
 

Depreciation and amortization

    11,840     14,063     36,334     42,036  
 

Capital expenditures

    2,433     4,505     7,470     11,025  
Reconciliation of segment operating income to consolidated operating income

 
  Three Months Ended   Nine Months Ended  
 
  September 24, 2011   September 25, 2010   September 24, 2011   September 25, 2010  

Total segment operating income

  $ 52,197   $ 47,995   $ 176,811   $ 152,175  

Unallocated corporate overhead

    (15,103 )   (11,527 )   (44,152 )   (55,528 )

Termination fee

        (30,000 )       (30,000 )
                   

Consolidated operating income

  $ 37,094   $ 6,468   $ 132,659   $ 66,647  
                   
Schedule of net sales for each significant service area

 
  Three Months Ended   Nine Months Ended  
 
  September 24, 2011   September 25, 2010   September 24, 2011   September 25, 2010  

Research models

  $ 86,386   $ 84,234   $ 269,976   $ 267,690  

Research model services

    54,539     50,575     161,936     153,536  

Other products

    30,546     24,450     91,093     77,378  
                   
 

Total research models

    171,471     159,259     523,005     498,604  
 

Total preclinical services

    106,108     111,626     328,680     353,160  
                   

Total sales

  $ 277,579   $ 270,885   $ 851,685   $ 851,764  
                   
Summary of unallocated corporate overhead

 
  Three Months Ended   Nine Months Ended  
 
  September 24, 2011   September 25, 2010   September 24, 2011   September 25, 2010  

Stock-based compensation expense

  $ 2,825   $ 3,249   $ 8,339   $ 9,864  

U.S. retirement plans

    501     1,162     2,613     2,819  

Audit, tax and related expenses

    855     659     2,115     1,858  

Salary and bonus

    3,187     4,144     12,522     13,443  

Global IT

    3,089     3,373     9,623     9,950  

Employee health and fringe cost

    (2,307 )   (1,776 )   7     (800 )

Consulting and professional services

    2,628     1,315     6,160     6,197  

Depreciation

    1,569     1,558     4,743     4,199  

Transaction (acquisition/disposition) costs

    251     (810 )   565     6,587  

Life insurance death benefit gain

            (7,710 )    

Other general unallocated corporate expenses

    2,505     (1,347 )   5,175     1,411  
                   

 

  $ 15,103   $ 11,527   $ 44,152   $ 55,528